Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,377 | -27,379 | -25,339 | -17,702 | -13,028 |
| Depreciation Amortization | 486 | 2,724 | 2,258 | 1,770 | 1,116 |
| Other Working Capital | -13,834 | -48,365 | -28,057 | -14,373 | -11,475 |
| Other Operating Activity | 2,542 | 9,407 | 6,963 | 4,628 | 2,268 |
| Operating Cash Flow | $-23,183 | $-63,613 | $-44,175 | $-25,677 | $-21,119 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -62,019 | -252,918 | -194,699 | -127,889 | -1,002 |
| PPE Investments | -109 | -1,359 | -1,125 | -959 | -230 |
| Sale Of Investment | 77,508 | 340,691 | 268,424 | 179,910 | 120,813 |
| Investing Cash Flow | $15,380 | $86,414 | $72,600 | $51,062 | $119,581 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 69 | 1,546 | 1,299 | 1,165 | 784 |
| Financing Cash Flow | $69 | $1,546 | $1,299 | $1,165 | $784 |
| Beginning Cash Position | 49,176 | 24,829 | 24,829 | 24,829 | 24,829 |
| End Cash Position | 41,442 | 49,176 | 54,553 | 51,379 | 124,075 |
| Net Cash Flow | $-7,734 | $24,347 | $29,724 | $26,550 | $99,246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,183 | -63,613 | -44,175 | -25,677 | -21,119 |
| Capital Expenditure | -109 | -1,359 | -1,125 | -959 | -230 |
| Free Cash Flow | -23,292 | -64,972 | -45,300 | -26,636 | -21,349 |